While control-treated mice showed ALL-induced Il7-GFP downregulation in MSCs, mice treated with CXCR4 antagonist maintained IL7 expression within the normal range of mice without ALL (Figure 5F). The gene discussed is CXCR4; the disease is acute lymphoblastic leukemia.